Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Cardiologist
M.B.B.S., F.C.P.S (Medicine), F.C.P.S (Cardiology)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship Endocrinology and Diabetes
Endocrinologist
M.B.B.S., MSc., P.E.C
Internal Medicine Specialist
MBBS, M.D, Diplomat American Board of Internal Medicine
Internal Medicine Specialist
MBBS, M.D, Diplomat American Board of Internal Medicine
Internal Medicine Specialist
MBBS, FRCP, MRCP, DTCD, DTM, DTH
Diabetologist
M.B.B.S., F.C.P.S (Endocrinologist), F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures